Organizer: The Manhattan Institute. At this lunch briefing, experts discuss the impact of the Prescription Drug User Fee Act on the FDA’s drug review process, as well as patient access to safe and effective new drugs. To RSVP, please contact Samara Klar at (646) 839-3313 or [email protected]
Added by insideronline on June 17, 2008